Senior Scientist/Post-doctoral researcher Immunology-oncology, Cell biology – Kuopio Center for Gene and Cell Therapy (KCT)



Kuopio Center for Gene and Cell Therapy (KCT) is a modern research institute located in Kuopio, Finland. Our mission is to conduct high-level research on basic and translational fields of gene- and cell therapy. The centre’s niche is in the interface between academic, basic research and the commercial biotechnology industry. KCT provides an exciting environment for applied research and discovery, developing therapeutic products through Phase I clinical trials and utilizing some of the most advanced analytical and mechanistic proof-of-principle approaches in the sector. Opportunities for two highly motivated Senior Scientists have now opened at the KCT Immunotherapy Program to work in projects that revolve around cancer and immune cell genetic engineering. Both projects are already active in KCT and involve clinicians, academic teams and international collaborators.

Project 1. In this project, the successful candidate will be developing T and NK based cell therapy products for ovarian and brain cancers. Lentivirus technology and CRIPR-Cas will be utilized in genetic engineering of the cells for cancer targeting and improved performance in solid cancer treatments. The candidate will closely work together with KCT team developing clinical grade cell therapy product processes. KCT research team has already established in vitro and in vivo methods to further characterize and functionally test the developed products.

Project 2. In this project, the successful candidate will participate in establishing 3-D cultures and characterization of ovarian and brain tumors. Cell culture, immunological and molecular methods are extensively utilized. The candidate will also participate in single-cell sequencing and proteomics characterizations involving collaborative laboratories specialist in these techniques. The candidate will work together with KCT research team with extensive knowledge in cell biology, immunology and bioinformatics.

The successful candidates will be responsible for designing, implementing and overseeing the project. These duties will involve practical laboratory technologies, and therefore strong wet lab background is essential. This person will work closely together with internal project teams and external collaborators and therefore have excellent communication skills in English.


  • The successful applicant should hold or be about to obtain a PhD in a relevant field, such as cell biology, immunology, immuno-oncology or cancer biology.

Skills and experience in the following areas is highly desirable:

  •          Project management
  •          Strong overall wet lab experience
  •          Cell biology methods, like primary cell isolation, 3D organoid culture, functional assays
  •          Multicolor flow cytometry – panel design and data analysis
  •          Gene editing technologies and advanced molecular methods
  •          Setting up and developing functional assays and analytical methods
  •      Furthermore, extensive understanding of such or related concepts as the human immune system activation and regulation or cancer immunosurveillance and cancer therapy is considered beneficial
  •          Excellent teamwork and communication skills in English are essential

Main responsibilities:

  •          Both job opportunities are Senior Scientist positions

The positions are initially for three years. International candidates are strongly encouraged to apply. KCT’s HR team are available to help with issues related to relocation.

Sent your cover letter and CV latest 22nd September 2019.

Further information (fistname.lastname@kct.fi):

Tuija Kekarainen, Cell Therapy Unit Director

Anssi Kailaanmäki, Head of Immunology

Katja Puttonen, Head of Process Development

Johanna Pirinen, HR Director